Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SHR-2554 by Jiangsu Hengrui Medicine for Peripheral T-Cell Lymphomas (PTCL): Likelihood of Approval
SHR-2554 is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Peripheral T-Cell Lymphomas (PTCL). According...